Corporate Support
Sitemap

Features

Customer Services

Events

Terms of Use

Singapore
Malaysia

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,194.7
21.8 (0.69%)

 

  • STI Straits Times Index
    3,194.7
    21.8 (0.69%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,567.3
    4.2 (0.27%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,994.1
    348.7 (1.31%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,915.7
    -8.7 (-0.30%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,424.8
    33.0 (0.14%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,139.4
    -40.7 (-0.66%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,137.3
    31.7 (1.51%)
    Index delayed 20 minutes
  • XAO XAO
    6,810.8
    -42.4 (-0.62%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 865.4M
  • Value: 1,189.2M
  • Rise: 151
  • Fall: 134
  • Unch: 541

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol

  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.179+0.012
Golden Agri-Res0.220-0.005
YZJ Shipbldg SGD1.090+0.010
Tritech0.024+0.001
GSS Energy0.084+0.006
Mapletree Com Tr2.280-0.050
SingTel3.390+0.030
CapitaMall Trust2.460-0.040
Ascendas Reit2.990-0.020
Genting Sing0.935+0.015

World Indices

World Indices
Name Last Change
Nasdaq 8,654.1 +37.9
HSI 26,994.1 +348.7
HSCEI 10,614.8 +112.2
Jakarta 6,139.4 -40.7
Nikkei 225 23,424.8 +33.0
SSE Comp 2,915.7 -8.7
Shanghai A 3,055.2 -9.1
Shanghai B 242.7 -1.4
PSE Comp 0.0
KOSPI 2,137.3 +31.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help

  • Factsheet

  • Print

IMUGENE LIMITED IMUGENE
Updated on 12 Dec 2019 (End of trading day)
Last (AUD): 0.030 Change: -0.001 High: 0.032 Remarks: -
Change (%): -3.23 Low: 0.029
Open 0.031 Yesterday's Close 0.031
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 29,108,750 Cumulative Value
 
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.00176 Trailing EPS (AUD) e -0.00176 NAV (AUD) b 0.0062
PE a - Trailing PE f - Price / NAV b 4.8387
Dividend (AUD) d - Cash In Hand (AUD) g 0.0043 Issued & Paid-up Shares c 4,425,970,000
Dividend Yield (%) d - Price / Cash In Hand g 6.977 Treasury Shares h -
Beta - 75 Daysi 0.241 R-Squared - 75 Days(%)i - Market Cap (M) 132.779
Beta - 500 Daysi 1.250 R-Squared - 500 Days (%)i 2.01 Enterprise Value (M) 113.854
Piotroski F Score 0 Exchange Code IMU Par Value ( AUD ) n.a.
52 Weeks Volatility (%) 88.49 Free Float (%) 76.7
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 09 Dec 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 16 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference IMUGENE LIMITED ASX 132.779 - - 4.8387 -
Industry Biotechnology ASX 2,634.273 58.952 58.321 15.4702 0.896
Local Peer CSL ASX 126,715.407 47.230 47.230 16.9334 0.950
Local Peer AVITA MEDICAL LTD ASX 1,143.428 - - 38.2979 -
Local Peer POLYNOVO LIMITED ASX 1,146.988 - - 43.9241 -
Local Peer MESOBLAST LTD ASX 1,002.377 - - 1.4228 -
Local Peer STARPHARMA HOLDINGS LIMITED ASX 476.780 - - 11.2478 -
Local Peer TELIX PHARMACEUTIC ASX 364.723 - - 8.4408 -
Local Peer NEXT SCIENCE LTD ASX 301.982 - - 8.6811 -
Local Peer NEUREN PHARMACEUTICALS LTD ASX 255.862 83.249 - 15.2522 -
Local Peer RESAPP HEALTH LIMITED ASX 167.101 - - 21.8182 -
Local Peer PYC THERAPEUTICS LIMITED ASX 164.160 - - 26.6667 -
Local Peer CYNATA THERAPEUTICS LTD ASX 111.775 - - 10.1878 -
Local Peer ONCOSIL MEDICAL LIMITED ASX 100.913 - - 9.4675 -
Other Local Peers IMMUTEP LTD (ASX), ORTHOCELL LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), KAZIA THERAPEUTICS LIMITED (ASX), BIONOMICS LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), NOVITA HEALTHCARE LTD (ASX), MEMPHASYS LTD (ASX), RHINOMED LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), BIOTRON (ASX), PROTEOMICS INTL LABORATORIES LTD (ASX), IMMURON LIMITED (ASX), ANTEOTECH LIMITED (ASX), CELLMID LIMITED (ASX), PATRYS LIMITED (ASX), REGENEUS LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), GENETIC TECHNOLOGIES (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), CCP TECHNOLOGIES LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), ADALTA LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), BENITEC BIOPHARMA LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), SIENNA CANCER DIAGNOSTICS LTD (ASX), TBG DIAGNOSTICS LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), BIOXYNE LIMITED (ASX), MEDIBIO LIMITED (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), BPH ENERGY LIMITED (ASX), NANOLLOSE LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Global Peer AMGEN INC NASDAQ 139,044.998 16.565 17.236 12.7249 2.391
Global Peer GILEAD SCIENCES INC NASDAQ 85,751.867 15.720 31.843 4.1619 3.409
Global Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Global Peer VERTEX PHARMACEUTICAL NASDAQ 56,573.000 26.986 26.390 10.7688 -
Global Peer BIOGEN INC NASDAQ 52,730.566 11.901 9.773 3.7676 -
Global Peer ILLUMINA INC NASDAQ 47,123.790 57.051 48.431 10.6158 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 41,012.089 16.778 19.127 3.9043 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 25,815.821 81.695 24.104 5.4372 0.734
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 24,231.364 312.259 16.481 2.3373 -
Global Peer INCYTE CORPORATION NASDAQ 20,447.637 186.749 50.492 8.4406 -
Other Global Peers SEATTLE GENETICS INC (NASDAQ), SINO BIOPHARM (HKEx), WUXI BIO (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BEIGENE (HKEx), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), MODERNA INC (NASDAQ), EXELIXIS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), BLUEBIRD BIO INC (NASDAQ), REPLIGEN CORP (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), GENSCRIPT BIO (HKEx), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), Lonza (SGX), IMMUNOMEDICS INC (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), 3SBIO (HKEx), ALLOGENE THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), NATERA INC (NASDAQ), UNIQURE N.V. (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), HALOZYME THERAPEUTICS INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), ACCELERON PHARMA (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), SYNTHORX INC (NASDAQ), XENCOR INC (NASDAQ), INSMED INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), HAOHAI BIOTEC (HKEx), ARVINAS INC (NASDAQ), EPIZYME INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), REGENXBIO INC (NASDAQ), VIELA BIO INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), VIR BIOTECHNOLOGY INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), VERACYTE INC (NASDAQ), NEXTCURE INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), FRONTAGE (HKEx), ROCKET PHARMACEUTICALS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), OPKO HEALTH INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), CKLIFE SCIENCES (HKEx), LUMINEX CORP(DEL) (NASDAQ), INTREXON CORP (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), CORTEXYME INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), VIVA BIOTECH (HKEx), ACHILLION PHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ASCENTAGE-B (HKEx), XBIOTECH INC (NASDAQ), KADMON HLDGS INC (NYSE), FLEXION THERAPEUTICS INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), UROGEN PHARMA LTD (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), DERMIRA INC (NASDAQ), AVROBIO INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), ARDELYX INC (NASDAQ), RETROPHIN INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), AGENUS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), SINOMAB BIO-B (HKEx), FREQUENCY THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), MERUS B V (NASDAQ), MACROGENICS INC (NASDAQ), ASCLETIS-B (HKEx), SINOVAC BIOTECH LTD (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), ESSEX BIO-TECH (HKEx), BIOCRYST PHARMACEUTICALS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), PDL BIOPHARMA INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), BELLUS HEALTH INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), COMPUGEN (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), KAMADA (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), PERSONALIS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), GERON CORP (NASDAQ), CUE BIOPHARMA INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), SERES THERAPEUTICS (NASDAQ), LEE'S PHARM (HKEx), ELOXX PHARMACEUTICALS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), PFENEX INC (NYSE American), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), IVERIC BIO INC (NASDAQ), DPHARMA (Bursa), CHIASMA INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), XOMA CORP (NASDAQ), ATHERSYS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CABALETTA BIO INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), NANTKWEST INC (NASDAQ), ARAVIVE INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), BBI LIFE SCI (HKEx), FIVE PRIME THERAPEUTICS (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), IMV INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ALDEYRA THERAPEUTICS (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), NANOVIRICIDES INC (NYSE American), FORTRESS BIOTECH INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), UNI-BIO GROUP (HKEx), LIMINAL BIOSCIENCES INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), ENZO BIOCHEM INC (NYSE), AXOVANT GENE THERAPIES LTD (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), CHIMERIX INC (NASDAQ), SESEN BIO INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), NOVAVAX INC (NASDAQ), VERASTEM INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), PARATEK PHARMACEUTICALS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), ADURO BIOTECH INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), SYNLOGIC INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), EQUILLIUM INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), VACCINEX INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), VERMILLION INC (NASDAQ), CEL-SCI CORP (NYSE American), COHBAR INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), TREVENA INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), CURIS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), INMUNE BIO INC (NASDAQ), SAVARA INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), CT ENTERPRISE (HKEx), RESTORBIO INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ORGENESIS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), PORT (SET), ARMATA PHARMACEUTICALS INC (NYSE American), NEON THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), BIOSINO BIO-TEC (HKEx), SUNESIS PHARMACEUTICALS INC (NASDAQ), ISORAY INC (NYSE American), EVOGENE LTD (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ZAFGEN INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), REGENT PACIFIC (HKEx), APTEVO THERAPEUTICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), ORAGENICS INC (NYSE American), SOLIGENIX INC (NASDAQ), CONTRAFECT CORP (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), IBIO INC (NYSE American), CORREVIO PHARMA CORP (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), EXTRAWELL PHAR (HKEx), INDIA GLOBALIZATION CAPITAL INC (NYSE American), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), TOCAGEN INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), ATYR PHARMA INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), DARE BIOSCIENCE INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ADVAXIS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), SENESTECH INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), PRECIPIO INC (NASDAQ), Suntar Eco-City^ (SGX), OCUGEN INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), BIOCEPT INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), TRILLIUM THERAPEUTICS INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), TROVAGENE INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), ARCA BIOPHARMA INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), MEGASUN (Bursa), REXAHN PHARMACEUTICALS INC (NASDAQ), MGRC (Bursa), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), HAO WEN HLDGS (HKEx), ENDRA LIFE SCIENCES INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), OPGEN INC (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), SPHERIX INC (NASDAQ), QT Vascular (SGX), AURIS MEDICAL HOLDING LTD (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.006
-16.67 %
10 Days --0.014
-31.82 %
20 Days --0.012
-28.57 %
Medium Term Return 3 Months -+0.006
+25.00 %
6 Months -+0.014
+87.50 %
1 Year -+0.008
+36.36 %
Long Term Return 2 Years -+0.014
+87.50 %
3 Years -+0.016
+114.29 %
5 Years -+0.020
+200.00 %
Annualised Return Annualised --
+24.57 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.013 - 0.063 Change From 1 Year Low +0.017 % Change From 1 Year Low (%) +130.77
Change From 1 Year High -0.033 % Change From 1 Year High (%) -52.38
2 Years Range 0.013 - 0.063 Change From 2 Years Low +0.017 % Change From 2 Years Low (%) +132.56
Change From 2 Years High -0.033 % Change From 2 Years High (%) -52.38
5 Years Range 0.007 - 0.063 Change From 5 Years Low +0.023 % Change From 5 Years Low (%) +334.78
Change From 5 Years High -0.033 % Change From 5 Years High (%) -52.38
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialisation of health technologies against cancer. Its products include b-cell peptide cancer vaccines, arginine modulators, and mimotopes. The company was founded on May 30, 1986 and is headquartered in Carlton, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
12 Dec 2019 0.031 0.032 0.029 0.030 29,108,750 -
11 Dec 2019 0.033 0.033 0.030 0.031 35,001,750 -
10 Dec 2019 0.033 0.034 0.032 0.033 21,958,940 -
09 Dec 2019 0.035 0.035 0.032 0.034 31,989,610 -
06 Dec 2019 0.036 0.037 0.034 0.037 50,783,740 -
05 Dec 2019 0.038 0.039 0.036 0.036 44,267,400 -
04 Dec 2019 0.039 0.039 0.037 0.039 30,559,340 -
03 Dec 2019 0.039 0.041 0.038 0.039 47,327,440 -
02 Dec 2019 0.039 0.042 0.037 0.040 75,898,940 -
29 Nov 2019 0.044 0.044 0.044 0.044 - -
28 Nov 2019 0.049 0.049 0.043 0.044 54,844,670 -
27 Nov 2019 0.049 0.049 0.043 0.044 54,844,670 -
26 Nov 2019 0.052 0.053 0.050 0.050 34,976,240 -
25 Nov 2019 0.056 0.057 0.051 0.052 53,998,830 -
22 Nov 2019 0.062 0.063 0.056 0.057 100,021,500 -
21 Nov 2019 0.054 0.060 0.054 0.060 98,976,340 -
20 Nov 2019 0.053 0.055 0.051 0.053 53,994,300 -
19 Nov 2019 0.058 0.060 0.049 0.052 112,976,400 -
18 Nov 2019 0.047 0.063 0.047 0.053 258,815,400 -
15 Nov 2019 0.047 0.048 0.043 0.045 144,024,300 -
14 Nov 2019 0.032 0.042 0.031 0.042 110,982,300 -
13 Nov 2019 0.033 0.034 0.031 0.031 36,015,260 -
Summary
Current 2 Weeks
(29 Nov 2019 to 12 Dec 2019)		 0.044 0.044 0.029 0.030 366,895,910 -
Previous 2 Weeks
(15 Nov 2019 to 28 Nov 2019)		 0.047 0.048 0.029 0.044 967,472,650 -
4 Weeks from
(18 Oct 2019 to 14 Nov 2019)		 0.022 0.044 0.020 0.042 645,520,115 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.